Position in CHRS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,370,200
-$511,216 QoQ
Shares Held
1,693,000
-0.7% QoQ
Ownership
1.10%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#12
of 145 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CHRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Hudson Bay Capital Management LP holds $565,820,903 across 77 Biotechnology names. CHRS ranks #36 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
390,440 | $193,943,261 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
825,002 | $47,206,614 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
148,720 | $44,769,181 | |
| 4 | BNTX |
BioNTech SE
|
260,000 | $24,193,000 | |
| 5 | IMCR |
Immunocore Holdings plc
|
590,000 | $18,732,500 | |
| 6 | TECH |
BIO-TECHNE Corp
|
200,000 | $14,130,000 | |
| 7 | VIR |
Vir Biotechnology, Inc.
|
1,364,000 | $13,899,160 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
159,778 | $13,033,091 |
All Filings in CHRS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,370,200 | 1,693,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,881,416 | 1,704,980 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,185,700 | 835,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,328,400 | 810,000 | Shares | Sole | 2025-12-15 | |
| 2025-06-30 | $610,385 | 835,000 | Shares | Sole | 2025-08-18 | |
| 2025-03-31 | $673,845 | 835,000 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,152,300 | 835,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $816,400 | 785,000 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,358,050 | 785,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,673,000 | 700,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,948,050 | 585,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,533,400 | 410,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,868,125 | 437,500 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,026,000 | 150,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,188,000 | 150,000 | Shares | Sole | 2023-02-14 | |
| 2022-06-30 | $1,122,200 | 155,000 | Shares | Sole | 2022-08-12 | |
| 2021-09-30 | $482,100 | 30,000 | Shares | Sole | 2021-12-29 | |
| 2021-06-30 | $1,175,550 | 85,000 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,351,425 | 92,500 | Shares | Sole | 2021-05-14 | |
| 2020-09-30 | $825,300 | 45,000 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,250,200 | 70,000 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $729,900 | 45,000 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||